| OAB2602 | Efficacy and safety of bictegravir plus lenacapavir: 48-week outcomes in virologically suppressed people with HIV-1 on complex antiretroviral regimens at baseline | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
| OAD0703 | “Bluetoothing”: knowledge, attitudes and behaviour on unsafe drug injection behaviour and its risks to HIV transmission among adolescents and young people in Zimbabwe | Oral abstract session with live Q&A | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
| OAB3605 | A pilot study assessing changes in cerebral function parameters in persons with insomnia switching integrase inhibitors | Oral abstract session with live Q&A | Co-morbidities and clinical complications of HIV and antiretroviral therapy |
| OAC1003 | Leading the way: indigenous communities successfully advancing HIV care outcomes post-pandemic | Oral abstract session with live Q&A | Integration of HIV services with other services, including sexual and reproductive health |
| OAD1905 | Exploring uncharted territories: understanding adolescent sexuality, gender, and HIV risk among refugee girls in Southwestern Uganda | Oral abstract session with live Q&A | Sexuality, gender, relationships and sexual cultures |
| OAF3105 | Bridging the divide and channelling support for parliamentarians to influence the repealing of “Bad” laws Africa, a case of the decriminalisation of HIV transmission in Zimbabwe 2022 | Oral abstract session with live Q&A | Human rights and responses to HIV |
| OAF2702 | Promoting access to HIV services among men-who-have-sex-with-men under a harsh environment in the wake of the anti-LGBTQ+ debate in Ghana | Oral abstract session with live Q&A | Political drivers and policy contexts of HIV |
| OAB2604 | Subcutaneous injections of cabotegravir + rilpivirine in virally suppressed adults with HIV-1: a substudy of the Phase 3 FLAIR study | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
| OAA0202 | Consecutive analytical treatment interruption enhances CD8 T-cell functionality during virological control | Oral abstract session with live Q&A | Host immune responses |
| OAA0205 | Experimental macaque model of post-treatment SIV control presents distinct features of viral reservoirs in blood and tissues, the pVISCONTI study | Oral abstract session with live Q&A | Understanding and targeting persistent HIV reservoirs |
